These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8896408)

  • 1. Blood clotting in minimally altered whole blood.
    Rand MD; Lock JB; van't Veer C; Gaffney DP; Mann KG
    Blood; 1996 Nov; 88(9):3432-45. PubMed ID: 8896408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation in hemophilia A and hemophilia C.
    Cawthern KM; van 't Veer C; Lock JB; DiLorenzo ME; Branda RF; Mann KG
    Blood; 1998 Jun; 91(12):4581-92. PubMed ID: 9616154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin functions during tissue factor-induced blood coagulation.
    Brummel KE; Paradis SG; Butenas S; Mann KG
    Blood; 2002 Jul; 100(1):148-52. PubMed ID: 12070020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents in tissue factor-induced blood coagulation.
    Butenas S; Cawthern KM; van't Veer C; DiLorenzo ME; Lock JB; Mann KG
    Blood; 2001 Apr; 97(8):2314-22. PubMed ID: 11290593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation at the site of microvascular injury: effects of low-dose aspirin.
    Undas A; Brummel K; Musial J; Mann KG; Szczeklik A
    Blood; 2001 Oct; 98(8):2423-31. PubMed ID: 11588039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S; Chen J; Diamond SL
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
    Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor.
    van 't Veer C; Golden NJ; Kalafatis M; Mann KG
    J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo.
    Perzborn E; Heitmeier S; Buetehorn U; Laux V
    J Thromb Haemost; 2014 Jul; 12(7):1054-65. PubMed ID: 24766850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A control switch for prothrombinase: characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation.
    Bukys MA; Kim PY; Nesheim ME; Kalafatis M
    J Biol Chem; 2006 Dec; 281(51):39194-204. PubMed ID: 17020886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow and the inhibition of prothrombinase by antithrombin III and heparin.
    Schoen P; Lindhout T
    Blood; 1991 Jul; 78(1):118-24. PubMed ID: 2070046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.
    Whelihan MF; Zachary V; Orfeo T; Mann KG
    Blood; 2012 Nov; 120(18):3837-45. PubMed ID: 22968460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism.
    Krishnaswamy S; Church WR; Nesheim ME; Mann KG
    J Biol Chem; 1987 Mar; 262(7):3291-9. PubMed ID: 3818642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation: phenotypic quantitation.
    Brummel-Ziedins KE; Pouliot RL; Mann KG
    J Thromb Haemost; 2004 Feb; 2(2):281-8. PubMed ID: 14995991
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.